(Q38413564)

2 September 2017

title

Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression (English)

1 reference

2 September 2017

Bilharzial vs non‐bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase‐2 expression (English)

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.2010.09854.X

2 September 2024

1 reference

8

Yair Lotan

1 reference

2 September 2017

4

Shahrokh F Shariat

1 reference

2 September 2017

Ramy Youssef

1

1 reference

2 September 2017

Payal Kapur

2

1 reference

2 September 2017

Wareef Kabbani

3

1 reference

2 September 2017

Ahmed Mosbah

5

1 reference

2 September 2017

Hassan Abol-Enein

6

1 reference

2 September 2017

Mohamed Ghoniem

7

1 reference

2 September 2017

Shahrokh F. Shariat

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21105986

2 September 2024

language of work or name

1 reference

24 November 2010

1 reference

full work available at URL

2 September 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1464-410X.2010.09854.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21105986

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-410X.2010.09854.x

2 September 2024

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.2010.09854.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2010.09854.x/fullpdf

2 September 2024

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.2010.09854.X

2 September 2024

1 reference

2 September 2017

volume

108

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

31-37

1 reference

2 September 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Chronic inflammation and bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Bilharziasis of the genitourinary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Many actions of cyclooxygenase-2 in cellular dynamics and in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Cyclooxygenase-2 expression increases with the stage and grade in transitional cell carcinoma of the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Prostaglandins and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Aspirin intake and survival after breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2010.09854.X

Incidence analyses of bladder cancer in the Nile delta region of Egypt

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.2010.09854.X

Cyclooxygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma

2 September 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.2010.09854.X

Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder

2 September 2024

17

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.2010.09854.X

Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer

2 September 2024

19

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.2010.09854.X

Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder

2 September 2024

26

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.2010.09854.X

2 September 2024

Identifiers

1 reference

2 September 2017

1 reference